Research and development

View all stories
Rebeca Plank, M.D., Ph.D. (right) and Joan Nabawanuka, community liaison officer at MU-JHU Care Ltd., meet with Kibuuka Yahaya Galabuzi, local leader of Katiko Fishing Village in the Mityana district

Building trust and advancing inclusion: Our approach to clinical trials in Uganda

In Uganda, where women are disproportionately impacted by HIV, our community-based research prioritizes meeting patients where they are

Understanding vision-threatening retinal conditions: Diabetic macular edema and wet AMD

Our scientists are researching new ways to address vision-threatening retinal conditions like diabetic macular edema and wet age-related macular degeneration (wet AMD)

senior couple making medical appointment

Debunking 6 common myths about pneumonia in adults

Don't underestimate the severity of this infection of the lungs

Macrocyclic peptides-

Macrocyclic peptides: a new research frontier

MSD scientists are exploring macrocyclic peptides, a new way to combine the properties of a biologic in a pill

Exploring KRAS: A precision approach in oncology

MSD scientists research oncogene mutations driving cancer growth

Plank and Howell

Meet two scientists at the forefront of our HIV research

Two esteemed scientists share their motivations and hopes for the future of HIV research

A lifelong commitment to addressing dengue fever

How our colleague’s personal experience fueled his desire to help others

We're pursuing innovative science with antibody-drug conjugate (ADC) research

MSD scientists are evaluating ADCs to explore novel treatment approaches in both solid tumors and blood cancers

Dr. Wilck and Dr. Platt

A personal commitment to public health

Stories of research and clinical care from two leading experts in pneumococcal and pediatric infectious disease

Scientist

AI optimizes the quest for small molecules

Our scientists harness rapidly evolving tech in small molecule lead optimization, which aims to improve biological activity, target selectivity and potential for toxicity

illustration of an octopus multitasking

Our researchers incorporate LLMs to accelerate drug discovery and development

What are artificial intelligence (AI) agents? They're intelligent systems combining large language models (LLM), AI models and tools to iteratively plan, execute and optimize tasks

Mic with soundwaves

Podcast: How AI can improve insight into disease biology

A scientist explains how we’re using AI capabilities to help identify patterns in tissue and tumor samples indiscernible to the human eye

patient and doctor

Building on our understanding of gynecologic cancers

How we’re driving research forward for women with common types of gynecologic cancer

TL1A CallOutImage

TL1A: Exploring a potentially important target for inflammatory bowel disease

Our scientists are investigating ways to modulate TL1A to potentially address inflammation and fibrosis associated with inflammatory bowel disease

Former CEO Dr. Roy Vagelos headshot

Our former CEO Dr. Roy Vagelos honored for role in helping China combat hepatitis B 

We’re proud of his recognition and our continued commitment to global health

Office meeting

What is One Pipeline?

How we’re advancing the best internal and external science to progress our pipeline for patients

Man is hazmat suit

A new foundation for future talent

We’re partnering with N.C. A&T to launch a collaborative biotechnology learning center

collage of scientists working in labs

How MSD scientists are driving next-generation cancer research

Our scientists are accelerating research by looking to improve anti-tumor immune response, targeting specific cancer cells and helping inhibit cancer growth

Scientist working in lab

Harnessing innovative technology in drug discovery

MSD scientists explain how new technologies can accelerate the drug discovery process as we use the power of leading edge science to save and improve lives

3 people in hard hats breaking ground

Breaking new ground in the UK

We’re accelerating our global efforts and capabilities with our new London Discovery Research Centre and U.K. headquarters

Scientist working in lab site

MSD’s legacy of antimicrobial innovation and action

Delivering on our commitment to fight infectious diseases for more than a century

Dr. Carmen La Rosa headshot

Meet the scientist advancing respiratory health and inspiring women and Latino scientists

Dr. Carmen La Rosa is uncovering new ways to help people with respiratory conditions

Members of MSD business development and licensing team

Podcast: Why neuroscience is the ‘final frontier’

Listen as specialists from MSD discuss what they’re most excited about in researching potential treatments for neurologic disorders

MSD's Dr. Jane Healy

Individualized neoantigen therapies: exploring one medicine for one patient

Scientists are researching new ways to help train the immune system to fight cancer

MSD scientist Denarra Simmons wearing goggles and lab coat in a lab

VIDEO: Here for Good – When passion and curiosity fuel innovation

Hear how one of our scientists balances her work and family life to accelerate our groundbreaking research

space shuttle launch

Proteins in space: taking our research to the final frontier

MSD Research Laboratories scientist Paul Reichert works with the International Space Station to drive innovation

Dr. Greg Lubiniecki headshot

Here for Good: The human element inspiring our cancer research

Learn how one doctor turned his family connection to cancer into a career driven by scientific innovation

people building with blocks illustration

When the world needs us, together we rise to the challenge

MSD CEO & President Rob Davis shares news with colleagues about our investigational COVID-19 medicine